A Study to Evaluate the Safety of QCZ484 in Healthy and Mild Hypertensive Subjects

Clinical trial NCT06905327 · COMPLETED

Trial details

NCT number: NCT06905327
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Mild Hypertension

Start date: 2023-03-08
Primary completion: 2024-09-25
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.